These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34964579)

  • 21. Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial.
    Nilsson PJ; van Etten B; Hospers GA; Påhlman L; van de Velde CJ; Beets-Tan RG; Blomqvist L; Beukema JC; Kapiteijn E; Marijnen CA; Nagtegaal ID; Wiggers T; Glimelius B
    BMC Cancer; 2013 Jun; 13():279. PubMed ID: 23742033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?
    São Julião GP; Habr-Gama A; Vailati BB; Aguilar PB; Sabbaga J; Araújo SEA; Mattacheo A; Alexandre FA; Fernandez LM; Gomes DB; Gama-Rodrigues J; Perez RO
    Eur J Surg Oncol; 2018 Jan; 44(1):93-99. PubMed ID: 29217398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer.
    Callender GG; Das P; Rodriguez-Bigas MA; Skibber JM; Crane CH; Krishnan S; Delclos ME; Feig BW
    Ann Surg Oncol; 2010 Feb; 17(2):441-7. PubMed ID: 19847569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
    Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
    BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.
    Voong KR; Rashid A; Crane CH; Minsky BD; Krishnan S; Yao JC; Wolff RA; Skibber JM; Feig BW; Chang GJ; Das P
    Am J Clin Oncol; 2017 Dec; 40(6):555-560. PubMed ID: 26237193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor response and negative distal resection margins of rectal cancer after hyperthermochemoradiation therapy.
    Tsutsumi S; Tabe Y; Fujii T; Yamaguchi S; Suto T; Yajima R; Morita H; Kato T; Shioya M; Saito J; Asao T; Nakano T; Kuwano H
    Anticancer Res; 2011 Nov; 31(11):3963-7. PubMed ID: 22110227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy.
    Pacelli F; Tortorelli AP; Rosa F; Bossola M; Sanchez AM; Papa V; Valentini V; Doglietto GB
    Ann Surg Oncol; 2010 Jan; 17(1):152-62. PubMed ID: 19834766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer.
    Velenik V; Oblak I; Anderluh F
    Radiat Oncol; 2010 Sep; 5():88. PubMed ID: 20920276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
    Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
    Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
    Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
    J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of locally recurrent rectal carcinoma--results and prognostic factors.
    Wong CS; Cummings BJ; Brierley JD; Catton CN; McLean M; Catton P; Hao Y
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):427-35. PubMed ID: 9457832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monthly tegafur-uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study.
    Kuo YH; Lai CH; Huang CY; Chen CJ; Huang YC; Huang WS; Chin CC
    BMC Cancer; 2019 Aug; 19(1):815. PubMed ID: 31419963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial.
    Erlandsson J; Holm T; Pettersson D; Berglund Å; Cedermark B; Radu C; Johansson H; Machado M; Hjern F; Hallböök O; Syk I; Glimelius B; Martling A
    Lancet Oncol; 2017 Mar; 18(3):336-346. PubMed ID: 28190762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer.
    McCarthy K; Pearson K; Fulton R; Hewitt J
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008368. PubMed ID: 23235660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study.
    Appelt AL; Pløen J; Harling H; Jensen FS; Jensen LH; Jørgensen JC; Lindebjerg J; Rafaelsen SR; Jakobsen A
    Lancet Oncol; 2015 Aug; 16(8):919-27. PubMed ID: 26156652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative combined radiotherapy and chemotherapy for middle and lower rectal cancer: preliminary results.
    Pucciarelli S; Friso ML; Toppan P; Fornasiero A; Carnio S; Marchiori E; Lise M
    Ann Surg Oncol; 2000; 7(1):38-44. PubMed ID: 10674447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraoperative radiotherapy in the combination of adjuvant chemotherapy for the treatment of pT3N0M0 rectal cancer after radical surgery.
    Zhang Q; Tey J; Yang Z; Li P; Peng L; Jiang R; Xiong F; Fu S; Lu JJ
    Am J Clin Oncol; 2014 Feb; 37(1):8-12. PubMed ID: 22892433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined modality therapy for rectal cancer: the relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence.
    Song S; Hong JC; McDonnell SE; Koong AC; Minsky BD; Chang DT; Liauw SL
    Ann Surg Oncol; 2012 Aug; 19(8):2471-6. PubMed ID: 22327251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service.
    Enker WE; Merchant N; Cohen AM; Lanouette NM; Swallow C; Guillem J; Paty P; Minsky B; Weyrauch K; Quan SH
    Ann Surg; 1999 Oct; 230(4):544-52; discussion 552-4. PubMed ID: 10522724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Use of Re-irradiation in Locally Recurrent, Non-metastatic Rectal Cancer.
    Susko M; Lee J; Salama J; Thomas S; Uronis H; Hsu D; Migaly J; Willett C; Czito B; Palta M
    Ann Surg Oncol; 2016 Oct; 23(11):3609-3615. PubMed ID: 27169769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.